Replies to post #429560 on NorthWest Biotherapeutics Inc (NWBO)

[The Danish Dude]

I am Trying to summon doctors Rago and Keister on Twitter.

[The Danish Dude]

Answer from Justin

[ATLnsider]

This is very interesting. It appears that an enhanced antigen specific Th1 immune response could be used to treat autoimmune diseases that are specific to the Th1 pathway:

How does this affect autoimmune disease?
In some people with autoimmune disease, patterns showing a dominance to either the Th1 or Th2 pathway have been shown. Although there are exceptions, the following table shows the conditions that are most commonly associated with a Th1 or Th2 dominant state:

TH1 dominant conditions:

Type I diabetes
Multiple sclerosis
Hashimoto’s Thyroiditis
Grave’s Disease
Crohn’s Disease
Psoriasis
Sjoren’s Syndrome
Celiac Disease
Lichen Planus
Rheumatoid Arthritis
Chronic viral infections

https://hypothyroidmom.com/autoimmune-patients-have-you-heard-of-th1-and-th2-dominance/

[CaptainObvious]

Tres cool

[The Danish Dude]

More from Justin:

"it’s reasonable to hypothesize that DC activation could be involved in complex and not well understood immune responses."

$NWBO it’s reasonable to hypothesize that DC activation could be involved in complex and not well understood immune responses. https://t.co/aoeylSy9vr

— Justin Keister MS DABR (@justinkeister5) December 25, 2021